486 related articles for article (PubMed ID: 32307242)
1. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
3. Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men.
Cole AP; Hanske J; Jiang W; Kwon NK; Lipsitz SR; Kathrins M; Learn PA; Sun M; Haider AH; Basaria S; Trinh QD
BJU Int; 2018 May; 121(5):811-818. PubMed ID: 29383868
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
[TBL] [Abstract][Full Text] [Related]
5. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
[TBL] [Abstract][Full Text] [Related]
6. Testosterone therapy and obstructive sleep apnea: is there a real connection?
Hanafy HM
J Sex Med; 2007 Sep; 4(5):1241-6. PubMed ID: 17645445
[TBL] [Abstract][Full Text] [Related]
7. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male.
Jones SD; Dukovac T; Sangkum P; Yafi FA; Hellstrom WJ
Sex Med Rev; 2015 Apr; 3(2):101-112. PubMed ID: 27784544
[TBL] [Abstract][Full Text] [Related]
9. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
10. Does untreated obstructive sleep apnea cause secondary erythrocytosis?
Nguyen CD; Holty JC
Respir Med; 2017 Sep; 130():27-34. PubMed ID: 29206630
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
[TBL] [Abstract][Full Text] [Related]
12. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
13. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
[TBL] [Abstract][Full Text] [Related]
14. Medical Treatments for Hypogonadism do not Significantly Increase the Risk of Deep Vein Thrombosis Over General Population Risk.
Kavoussi PK; Machen GL; Wenzel JL; Ellis AM; Kavoussi M; Kavoussi KM; Kavoussi SK
Urology; 2019 Feb; 124():127-130. PubMed ID: 30447269
[TBL] [Abstract][Full Text] [Related]
15. Exogenous Testosterone Replacement Therapy Is Associated with Increased Risk for Vascular Graft Infections Among Hypogonadal Men.
Longwolf KJ; Johnson CE; Horns JJ; Hotaling JM; Brooke BS
Ann Vasc Surg; 2023 Nov; 97():113-120. PubMed ID: 37453467
[TBL] [Abstract][Full Text] [Related]
16. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
17. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.
Hazegh K; Bravo MD; Kamel H; Dumont L; Kanias T
Transfusion; 2020 May; 60(5):947-954. PubMed ID: 32176332
[TBL] [Abstract][Full Text] [Related]
19. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.
Ip FF; di Pierro I; Brown R; Cunningham I; Handelsman DJ; Liu PY
Eur J Endocrinol; 2010 Feb; 162(2):385-90. PubMed ID: 19903801
[TBL] [Abstract][Full Text] [Related]
20. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
